HHT is a rare condition characterized by telangiectasia and congenital AF, and is caused by mutations in endoglin/CD105 and activin receptor-like kinase-1 (ALK1) [65,66]. Here, ACVRL1 is linked to hereditary hemorrhagic telangiectasia.